Nimble Therapeutics Spins Out of Roche
Nimble Therapeutics announced today that it has spun out from F. Hoffman-La Roche as a standalone biotech company. According to a release, Nimble Therapeutics will commercialize its proprietary chemical synthesis technology for…










